4//SEC Filing
Wright-Mitchell Jane 4
Accession 0001209191-21-011322
CIK 0001649094other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:55 PM ET
Size
9.1 KB
Accession
0001209191-21-011322
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Mitchell Jane Wright
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2021-02-16$2.03/sh+2,500$5,075→ 4,062 total - Sale
Common Stock
2021-02-16$26.95/sh−2,500$67,375→ 1,562 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-16−2,500→ 202,468 totalExercise: $2.03Exp: 2029-03-20→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $26.52 to $27.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001614568
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:55 PM ET
- Size
- 9.1 KB